Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • hollystephens723
    Member
    • Dec 2018
    • 36

    #1

    Announcing the COVID-19 Risk Factor Modeling Challenge on June 1st

    Identifying and improving our understanding of the risk and protective factors for severe COVID-19 illness is crucial to better protect, triage, and treat at-risk individuals. To date, researchers and medical professionals have identified several risk factors that are associated with greater risk for severe illness from COVID-19, but additional research is needed to better understand the impact these factors have on high-risk individuals. The Veteran population, in particular, has a higher prevalence of several of the known risk factors for severe COVID-19 illness. To improve our understanding of the risk and protective factors in the Veteran population, the VHA Innovation Ecosystem is utilizing the precisionFDA platform to call upon the public to develop machine learning and artificial intelligence models to predict health outcomes using synthetic Veteran health records.

    If you would like to learn more about the challenge and how the VHA Innovation Ecosystem and precisionFDA are working together to improve COVID-19 patient outcomes, please visit the challenge site! Pre-registration for the challenge opens today, and the challenge submission period runs from June 1st through July 1st.

    If you have any questions about the challenge, precisionFDA, or the VHA Innovation Ecosystem, please feel free to post them in this thread, and we will respond as quickly as possible.

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 07:41 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...